Most notably , Juno Therapeutics , a company developing CAR - T immunotherapy for cancer .
That raised $314 million in venture capital investments and had a $265 million initial public offering in 2014 , was started based on inventions made at the center .
Most notably , Juno Therapeutics , a company developing CAR - T immunotherapy for cancer and that raised $314 million in venture capital investments and had a $265 million initial public offering in 2014 , was started based on inventions made at the center .